A review on salient pharmacological features and chemical constituents of bitter melon
Abstract
Since prehistoric times, plants have been used as medicine and foodstuff across the world. The Cucurbitaceae family includes the Bitter Melon, Momordica charantia. The bitter melon plant is a vine with green leaves and yellow blooms, and the cucumber-like fruit is rectangular and green. It has been used as food and medicine for millennia in the Amazon, Asia, South America, India, East Africa, and the Caribbean. The name "Momordica" derives from the Latin word mordica, which means "to bite," and refers to the notched margins of the leaf that appear to have been bitten. The plant, also known as "bitter melon" or "bitter gourd," lives truly the case to its common name by being exceedingly bitter throughout, including the fruit. This review seeks to offer information on the distribution and cultivation of bitter gourd and also explain the chemical constituents and their biological or pharmacological activity of herbal drugs of Momordica charantia Linn. (Cucurbitaceae). Our first goal was to understand more about the different pharmacological activity of the plant and the mode of action through which the activity is responsible. This review gives a thorough knowledge of traditional use of Momordica charantia with its detailed botanical description. Momordica charantia includes a large number of chemically distinct compounds, needing intensive screening processes to determine the pharmacological effects of its phytoconstituents at the molecular level. Furthermore, the paper highlights the medicinal potential of its bioactive components as well as their use in value-added food items. It has the power to fight against numerous lifestyle-related ailments, such as cancer recurrence, diabetes mellitus, abdominal pain, kidney (stone), fever, and scabies, due to the presence of bioactive chemicals.
References
Puri R, Sud R, Khaliq A, Kumar M, Jain S. Gastrointestinal toxicity due to bitter bottle gourd (Lagenaria siceraria) ─ a report of 15 cases. Indian Journal of Gastroenterology. 2011 Sep;30(5):233-6.
Sabourian R, Karimpour-Razkenari E, Saeedi M, S Bagheri M, Khanavi M, Sadati N, Akbarzadeh T, RS Ardekani M. Medicinal plants used in Iranian traditional medicine (ITM) as contraceptive agents. Current pharmaceutical biotechnology. 2016 Sep 1;17(11):974-85.
Pandit S, Kanjilal S, Awasthi A, Chaudhary A, Banerjee D, Bhatt BN, Narwaria A, Singh R, Dutta K, Jaggi M, Singh AT. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay. Journal of ethnopharmacology. 2017 Feb 2; 197:165-72.
Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011 Dec 25;2(9):1000167.
Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D. A medicinal potency of Momordica charantia.
Yip CL. Bitter Melon: Stories from the Last Rural Chinese Town in America.
Beloin N, Gbeassor M, Akpagana K, Hudson J, de Soussa K, Koumaglo K, Arnason JT. Ethnomedicinal uses of Momordica charantia (Cucurbitaceae) in Togo and relation to its phytochemistry and biological activity. Journal of Ethnopharmacology. 2005 Jan 4;96(1-2):49-55.
Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. Journal of ethnopharmacology. 2004 Jul 1;93(1):123-32.
Ng TB, Chan WY, Yeung HW. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceae plants. General Pharmacology: The Vascular System. 1992 Jul 1;23(4):575-90.
Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. Journal of ethnopharmacology. 2000 Jul 1;71(1-2):23-43.
Zafar R. Momordica charantia-a review. Hamdard medicus. 1991;34(3):49-61.
Perveen A, Qaiser M. Pollen flora of Pakistan-LVI. Cucurbitaceae. Pakistan Journal of Botany. 2008 Feb 1;40(1):9.
Duke JA. CRC Handbook of Medicinal Herbs CRC Press. Inc., Boca Raton, FL, 1985.-677p. 1985.
Agarwal M, Kamal R. In vitro clonal propagation of Momordica charantia L.
Longo DL, Jameson JL, Kaspe D. Harrison's Principles of Internal Medicine: Volume 2. Macgraw-Hill; 2011.
Orji, E.E., Falodun, A.E. and Jegede, F.I., 2018. Biosciences and Plant Biology. Int. J. Curr. Res. Biosci. Plant Biol, 5(4), pp.30-35.
Naidu KC, Pullaiah T. Antidiabetic plants in India and herbal based antidiabetic research. Regency; 2003.
Koundal R, Rawat K, Agnihotri VK, Meena RL, Gopichand, Singh RD, Padwad YS. Temporal and spatial variation in quality of essential oil of Hedychium spicatum and evaluation of its antioxidant activity. Journal of essential oil research. 2015 May 4;27(3):217-24.
Council of Scientific and Industrial Research, Sastri BN. The Wealth of India: Dictionary of Indian Raw Materials & Industrial Products. Council of Scientific & Industrial Research (India). CSIR; 1953.
Yuwai KE, Rao KS, Kaluwin C, Jones GP, Rivett DE. Chemical composition of Momordica charantia L. fruits. Journal of Agricultural and Food Chemistry. 1991 Oct;39(10):1762-3.
Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D. A medicinal potency of Momordica charantia.
Warrier PK. Indian medicinal plants: a compendium of 500 species. Orient Blackswan; 1993.
Ahmad N, Hasan N, Ahmad Z, Zishan M, Zohrameena S. Momordica charantia: for traditional uses and pharmacological actions. Journal of Drug Delivery and Therapeutics. 2016 Mar 14;6(2):40-4.
Gupta M, Sharma S, Gautam AK, Bhadauria R. Momordica charantia Linn. (Karela): Nature’s silent healer. International Journal of Pharmaceutical Sciences Review and Research. 2011;11(1):32-7.
Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D. A medicinal potency of Momordica charantia.
Karim R, Begum MM, Jui Y, Islam T, Billah M, Arafat Y, Karim M, Khan AF, Rahman MS. In-vitro cytotoxic and anti-Vibrio cholerae activities of alcoholic extracts of Desmodium triflorum (L.) whole plant and Terminalia citrina (Roxb.) fruits. Clinical Phytoscience. 2021 Dec;7(1):1-0.
Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D. A medicinal potency of Momordica charantia.
Gupta M, Sharma S, Gautam AK, Bhadauria R. Momordica charantia Linn. (Karela): Nature’s silent healer. International Journal of Pharmaceutical Sciences Review and Research. 2011;11(1):32-7.
Gandhi PR, Jayaseelan C, Kamaraj C, Rajasree SR, Mary RR. In vitro antimalarial activity of synthesized TiO2 nanoparticles using Momordica charantia leaf extract against Plasmodium falciparum. Journal of Applied Biomedicine. 2018 Nov 1;16(4):378-86.
Braca A, Siciliano T, D’Arrigo M, Germanò MP. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapia. 2008 Feb 1;79(2):123-5.
Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D. A medicinal potency of Momordica charantia.
Dabas R, Kumar J, Rao RK, Tripathi JS. Indian Journal of Agriculture and Allied Sciences.
Gandhi PR, Jayaseelan C, Kamaraj C, Rajasree SR, Mary RR. In vitro antimalarial activity of synthesized TiO2 nanoparticles using Momordica charantia leaf extract against Plasmodium falciparum. Journal of Applied Biomedicine. 2018 Nov 1;16(4):378-86.
Agharkar SP. Medicinal plants of Bombay presidency.
Celia G, Jaipaul S. Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review.
Zhang F, Lin L, Xie J. A mini-review of chemical and biological properties of polysaccharides from Momordica charantia. Int J Biol Macromol. 2016 Nov; 92:246-253. doi: 10.1016/j.ijbiomac.2016.06.101. Epub 2016 Jul 1. PMID: 27377459.
Ng TB, Wong CM, Li WW, Yeung HW. Peptides with antilipolytic and lipogenic activities from seeds of the bitter gourd Momordica charantia (family Cucurbitaceae). Gen Pharmacol. 1987;18(3):275-81. doi: 10.1016/0306-3623(87)90011-5. PMID: 3106137.
Dia VP, Krishnan HB. BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells. Sci Rep. 2016 Sep 15; 6:33532. doi: 10.1038/srep33532. PMID: 27628414; PMCID: PMC5024301.
Fernandes NP, Lagishetty CV, Panda VS, Naik SR. An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement Altern Med. 2007 Sep 24; 7:29. doi: 10.1186/1472-6882-7-29. PMID: 17892543; PMCID: PMC2048984.
Huang HT, Zhang LJ, Huang HC, Hwang SY, Wu CL, Lin YC, Liaw CC, Cheng YY, Morris-Natschke SL, Huang CY, Lee KH, Kuo YH. Cucurbitane-Type Triterpenoids from the Vines of Momordica charantia and Their Anti-inflammatory Activities. J Nat Prod. 2020 May 22;83(5):1400-1408. doi: 10.1021/acs.jnatprod.9b00592. Epub 2020 May 1. PMID: 32357011; PMCID: PMC8173961.
Namsa ND, Mandal M, Tangjang S, Mandal SC. Ethnobotany of the Monpa ethnic group at Arunachal Pradesh, India. J Ethnobiol Ethnomed. 2011 Oct 14; 7:31. doi: 10.1186/1746-4269-7-31. PMID: 21995750; PMCID: PMC3206407.
Farah N, Bukhari SA, Ali M, Naqvi SA, Mahmood S. Phenolic acid profiling and antiglycation studies of leaf and fruit extracts of tyrosine primed Momordica charantia seeds for possible treatment of diabetes mellitus. Pak J Pharm Sci. 2018 Nov;31(6 (Supplementary):2667-2672. PMID: 30587477.
Braca A, Siciliano T, D'Arrigo M, Germanò MP. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapia. 2008 Feb;79(2):123-5. doi: 10.1016/j.fitote.2007.11.002. Epub 2007 Dec 3. PMID: 18164872.
Kumar KS, Bhowmik D. Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn. International Journal of Pharmaceutical Sciences Review and Research. 2010;4(3):23-8.
Agharkar SP. Medicinal plants of Bombay presidency.
Celia G, Jaipaul S. Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review.
Donya A, Hettiarachchy N, Liyanage R, Lay J Jr, Chen P, Jalaluddin M. Effects of processing methods on the proximate composition and momordicosides K and L content of bitter melon vegetable. J. Agric. Food Chem. 2007; 55:5827–5833. [PubMed: 17567143]
Joseph B, Jini D. Antidiabetic effects of Momordia charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Dis. 2013; 3:93–102. Jadhav D. Medicinal Plants of Madhya Pradesh & Chhattisgarh. Delhi: Daya Publishing House; 2008.
Agharkar SP. Medicinal plants of Bombay presidency.
Dabas R, Kumar J, Rao RK, Tripathi JS. Indian Journal of Agriculture and Allied Sciences.
Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes care. 2013 Apr 1;36(4):914-21.
Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine. 1996 Mar 1;2(4):349-62.
Xu X, Shan B, Liao CH, Xie JH, Wen PW, Shi JY. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice. International journal of biological macromolecules. 2015 Nov 1; 81:538-43.
Arafat SY, Nayeem M, Jahan S, Karim Z, Reza HM, Hossain MH, Shohel M, Alam MA. Ellagic acid rich Momordica charantia fruit pulp supplementation prevented oxidative stress, fibrosis and inflammation in liver of alloxan induced diabetic rats. Oriental Pharmacy and Experimental Medicine. 2016 Dec;16(4):267-78.
Arafat SY, Nayeem M, Jahan S, Karim Z, Reza HM, Hossain MH, Shohel M, Alam MA. Ellagic acid rich Momordica charantia fruit pulp supplementation prevented oxidative stress, fibrosis and inflammation in liver of alloxan induced diabetic rats. Oriental Pharmacy and Experimental Medicine. 2016 Dec;16(4):267-78.
Czompa A, Gyongyosi A, Szoke K, Bak I, Csepanyi E, Haines DD, Tosaki A, Lekli I. Effects of Momordica charantia (Bitter Melon) on ischemic diabetic myocardium. Molecules. 2017 Mar;22(3):488.
Thent ZC, Das S, Zaidun NH. Emerging trends on drug delivery strategy of Momordica charantia against diabetes and its complications. Current Drug Delivery. 2018 May 1;15(4):453-60.
Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. Journal of ethnopharmacology. 1986 Sep 1;17(3):277-82.
Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine. 1996 Mar 1;2(4):349-62.
Bailey CJ, Day C, Leatherdale BA. Traditional treatments for diabetes from Asia and the West Indies. Practical Diabetes International. 1986 Jul;3(4):190-2.
Day C, Cartwright T, Provost J, Bailey CJ. Hypoglycaemic effect of Momordica charantia extracts. Planta medica. 1990 Oct;56(05):426-9.
Liu CH, Yen MH, Tsang SF, Gan KH, Hsu HY, Lin CN. Antioxidant triterpenoids from the stems of Momordica charantia. Food chemistry. 2010 Feb 1;118(3):751-6.
Bajpai M, Pande A, Tewari SK, Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. International journal of food sciences and nutrition. 2005 Jan 1;56(4):287-91.
Yibchok-Anun, S., S. Adisakwattana, C.Y. Yao, P. Sangamesh, S. Roengsumran and W.H. Hsu, 2006. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulin mimetic activities. Biol. Pharmaceut. Bull., 29: 1126-1131
Yadav, B. S.; Yadav, R.; Yadav, R. B.; Garg, M. Antioxidant Activity of Various Extracts of Selected Gourd Vegetables. Journal of Food Science 2016, 53(4), 1823–1833
Thenmozhi AJ, Subramanian P. Antioxidant potential of Momordica charantia in ammonium chloride-induced hyperammonemic rats. Evidence-Based Complementary and Alternative Medicine. 2011 Jan 1;2011.
Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK. Antihyperglycemic effects of three extracts from Momordica charantia. Journal of ethnopharmacology. 2003 Sep 1;88(1):107-11.
Lucas EA, Dumancas GG, Smith BJ, Clarke SL, Arjmandi BH. Health benefits of bitter melon (Momordica charantia). InBioactive Foods in Promoting Health 2010 Jan 1 (pp. 525-549). Academic Press.
Lucas EA, Dumancas GG, Smith BJ, Clarke SL, Arjmandi BH. Health benefits of bitter melon (Momordica charantia). InBioactive Foods in Promoting Health 2010 Jan 1 (pp. 525-549). Academic Press.
Horax R, Hettiarachchy N and Islam S: Total Phenolic contents and phenolic acid constituents in four varieties of bitter melons (Momordica charantia) and antioxidant activities of their extracts. J Food Sci 2005; 70
Stepka W, Wilson KE, Madge GE. Antifertility investigation on Momordica. Lloydia. 1974;37(4):645c.
Braca A, Siciliano T, D’Arrigo M, Germanò MP. Chemical composition and antimicrobial activity of Momordica charantia seed essential oil. Fitoterapia. 2008 Feb 1;79(2):123-5.
Mahmood A, Raja GK, Mahmood T, Gulfraz M, Khanum A. Isolation and characterization of antimicrobial activity conferring component (s) from seeds of bitter gourd (Momordica charantia). Journal of Medicinal Plants Research. 2012 Jan 30;6(4):566-73.
Mada SB, Garba A, Mohammed HA, Muhammad A, Olagunju A, Muhammad AB. Antimicrobial activity and phytochemical screening of aqueous and ethanol extracts of Momordica charantia L. leaves. Journal of Medicinal Plants Research. 2013 Mar 10;7(10):579-86.
Bourinbaiar AS, Leehuang S. Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon. Biochemical and biophysical research communications. 1995 Mar 17;208(2):779-85.
Lee-Huang S, Huang PL, Chen HC, Huang PL, Bourinbaiar A, Huang HI, Kung HF. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene. 1995 Aug 19;161(2):151-6.
Huang TM, Lee-Huang S, Huang PL, Chen HC. Studies on antiviral activity of the extract of Momordica charantia and its active principle. Virologica. 1988;5(4):367-73.
Gupta M, Sharma S, Gautam AK, Bhadauria R. Momordica charantia Linn. (Karela): Nature’s silent healer. International Journal of Pharmaceutical Sciences Review and Research. 2011;11(1):32-7.
Cunnick JE, Sakamoto K, Chapes SK, Fortner W, Takemoto DJ. Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). Cellular Immunology. 1990 Apr 1;126(2):278-89.
Bai J, Zhu Y, Dong Y. Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats. Journal of Ethnopharmacology. 2016 Dec 24; 194:717-26.
Bourinbaiar AS and Lee-Huang S: “The activity of plant derived antiretroviral proteins MAP30 and GAP31 against Herpes simplex virus in vitro.” Bioche Biophy Res Commun 219(3): 1996; 923–29.
Raina, K.; Kumar, D.; Agarwal, R. Promise of Bitter Melon (Momordica Charantia) Bio actives in Cancer Prevention and Therapy. Seminars Cancer Biology 2016, 40, 116–129. DOI: 10.1016/j.semcancer.2016.07.002.
Nerurkar, P. V.; Lee, Y. K.; Nerurkar, V. R. Momordica Charantia (Bitter Melon) Inhibits Primary Human Adipocyte Differentiation by Modulating Adipogenic Genes. BMC Complementary and Alternative Medicine 2010, 10, 34. DOI:10.1186/1472-6882-10-34.
Akihisa T, Higo N, Tokuda H, Ukiya M, Akazawa H, Tochigi Y, et al. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J. Nat. Prod. 2007; 70:1233–1239. [PubMed: 17685651].
Chaturvedi, P. Antidiabetic Potentials of Momordica Charantia: Multiple Mechanisms behind the Effects. Journal of Medical Food 2012, 15(2), 101–107. DOI: 10.1089/jmf.2010.0258.
[Yang, S. J.; Choi, J. M.; Park, S. E.; Rhee, E. J.; Lee, W. Y.; Oh, K. W.; Park, S. W.; Park, C. Y. Preventive Effects of Bitter Melon (Momordica Charantia) against Insulin Resistance and Diabetes are Associated with the Inhibition of NF-κB and JNK Pathways in High-Fat-Fed OLETF Rats. Journal of Nutritional Biochemistry 2015, 26(3), 234–240. DOI: 10.1016/j.jnutbio.2014.10.010